NovoCure Ltd Insider Trading for April 2019
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in NovoCure Ltd.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in NovoCure Ltd for April 2019.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 12 2019 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Option Exercise | M | 3.44 | 5,000 | 17,200 | 64,743 | |
| Apr 12 2019 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Sell | S | 45.95 | 5,000 | 229,750 | 60,000 | 65 K to 60 K (-7.69 %) |
| Apr 12 2019 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Buy | M | 3.44 | 5,000 | 17,200 | 65,000 | 60 K to 65 K (+8.33 %) |
| Apr 03 2019 | NVCR | NovoCure Ltd | Ambrogi Michael J. | Chief Operating Off ... | Option Exercise | M | 14.37 | 15,516 | 222,965 | 0 | |
| Apr 03 2019 | NVCR | NovoCure Ltd | Ambrogi Michael J. | Chief Operating Off ... | Option Exercise | M | 11.46 | 12,500 | 143,250 | 3,774 | |
| Apr 03 2019 | NVCR | NovoCure Ltd | Ambrogi Michael J. | Chief Operating Off ... | Option Exercise | M | 14.37 | 21,875 | 314,344 | 15,516 | |
| Apr 03 2019 | NVCR | NovoCure Ltd | Ambrogi Michael J. | Chief Operating Off ... | Sell | S | 47.83 | 132 | 6,314 | 185,674 | 185.8 K to 185.7 K (-0.07 %) |
| Apr 03 2019 | NVCR | NovoCure Ltd | Ambrogi Michael J. | Chief Operating Off ... | Sell | S | 47.24 | 15,384 | 726,725 | 185,806 | 201.2 K to 185.8 K (-7.65 %) |
| Apr 03 2019 | NVCR | NovoCure Ltd | Ambrogi Michael J. | Chief Operating Off ... | Buy | M | 14.37 | 15,516 | 222,965 | 201,190 | 185.7 K to 201.2 K (+8.36 %) |
| Apr 03 2019 | NVCR | NovoCure Ltd | Ambrogi Michael J. | Chief Operating Off ... | Sell | S | 48.09 | 1,298 | 62,418 | 185,674 | 187 K to 185.7 K (-0.69 %) |
| Apr 03 2019 | NVCR | NovoCure Ltd | Ambrogi Michael J. | Chief Operating Off ... | Sell | S | 47.39 | 11,202 | 530,896 | 186,972 | 198.2 K to 187 K (-5.65 %) |
| Apr 03 2019 | NVCR | NovoCure Ltd | Ambrogi Michael J. | Chief Operating Off ... | Buy | M | 11.46 | 12,500 | 143,250 | 198,174 | 185.7 K to 198.2 K (+6.73 %) |
| Apr 03 2019 | NVCR | NovoCure Ltd | Ambrogi Michael J. | Chief Operating Off ... | Sell | S | 48.07 | 1,600 | 76,915 | 185,674 | 187.3 K to 185.7 K (-0.85 %) |
| Apr 03 2019 | NVCR | NovoCure Ltd | Ambrogi Michael J. | Chief Operating Off ... | Sell | S | 47.29 | 20,275 | 958,784 | 187,274 | 207.5 K to 187.3 K (-9.77 %) |
| Apr 03 2019 | NVCR | NovoCure Ltd | Ambrogi Michael J. | Chief Operating Off ... | Buy | M | 14.37 | 21,875 | 314,344 | 207,549 | 185.7 K to 207.5 K (+11.78 %) |
| Apr 01 2019 | NVCR | NovoCure Ltd | Shah Pritesh | Chief Commercial Of ... | Option Exercise | M | 7.03 | 8,869 | 62,349 | 0 | |
| Apr 01 2019 | NVCR | NovoCure Ltd | Shah Pritesh | Chief Commercial Of ... | Option Exercise | M | 6.72 | 23,652 | 158,941 | 0 | |
| Apr 01 2019 | NVCR | NovoCure Ltd | Shah Pritesh | Chief Commercial Of ... | Buy | M | 7.03 | 8,869 | 62,349 | 76,212 | 67.3 K to 76.2 K (+13.17 %) |
| Apr 01 2019 | NVCR | NovoCure Ltd | Shah Pritesh | Chief Commercial Of ... | Buy | M | 6.72 | 23,652 | 158,941 | 67,343 | 43.7 K to 67.3 K (+54.13 %) |